|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Equity-based compensation | |||||
| Deferred income taxes | |||||
| Other adjustments | |||||
| Changes in certain assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Other assets | |||||
| Accounts payable | |||||
| Income taxes receivable/payable | |||||
| Accrued expenses | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Purchases of property, plant and equipment | |||||
| Purchases of short-term investments | |||||
| Proceeds from maturities of short-term investments | |||||
| Business combinations, net of cash acquired | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Issuance of current and long-term debt | |||||
| Repayment of current and long-term debt | |||||
| Dividends paid | |||||
| Purchases of treasury stock | |||||
| Other financing activities | |||||
| Net cash used in financing activities | |||||
| Increase (decrease) in cash and equivalents, and restricted cash | |||||
| Cash and equivalents, and restricted cash at beginning of period | |||||
| Cash and equivalents, and restricted cash at end of period | |||||
| Supplemental disclosure information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net | |||||
Loading...